Your browser doesn't support javascript.
loading
Auranofin inhibits the occurrence of colorectal cancer by promoting mTOR-dependent autophagy and inhibiting epithelial-mesenchymal transformation.
Zhang, Mei; Yang, Dong-Yuan; He, Zhi-Yi; Wu, Yu; Tian, Xiu-Yun; Huang, Qing-Yang; Ma, Wang-Bo; Deng, Min; Wang, Qi-Zhi; Yan, Shan-Jun; Zheng, Hai-Lun.
Afiliación
  • Zhang M; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Yang DY; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • He ZY; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Wu Y; School of Pharmacy, Bengbu Medical College/Anhui Biochemical Drug Engineering Technology Research Center, Bengbu, China.
  • Tian XY; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Huang QY; School of Pharmacy, Bengbu Medical College/Anhui Biochemical Drug Engineering Technology Research Center, Bengbu, China.
  • Ma WB; School of Pharmacy, Bengbu Medical College/Anhui Biochemical Drug Engineering Technology Research Center, Bengbu, China.
  • Deng M; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Wang QZ; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Yan SJ; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
  • Zheng HL; Department of Gastroenterology, the First Affiliated Hospital of Bengbu Medical College.
Anticancer Drugs ; 35(2): 129-139, 2024 02 01.
Article en En | MEDLINE | ID: mdl-37615540

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Auranofina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Auranofina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2024 Tipo del documento: Article